Fast Market Research

Report Published: "High Point Pharmaceuticals, LLC - Product Pipeline Review - 2013"

Recently published research from Global Markets Direct, "High Point Pharmaceuticals, LLC - Product Pipeline Review - 2013", is now available at Fast Market Research

 
Repost This

Boston, MA -- (SBWIRE) -- 02/03/2014 -- Global Market Direct's pharmaceuticals report, "High Point Pharmaceuticals, LLC - Product Pipeline Review - 2013" provides data on the High Point Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, High Point Pharmaceuticals, LLC's corporate website, SEC filings, investor presentations and featured press releases, both from High Point Pharmaceuticals, LLC and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- High Point Pharmaceuticals, LLC - Brief High Point Pharmaceuticals, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of High Point Pharmaceuticals, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of High Point Pharmaceuticals, LLC with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the High Point Pharmaceuticals, LLC's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate High Point Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of High Point Pharmaceuticals, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the High Point Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with High Point Pharmaceuticals, LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of High Point Pharmaceuticals, LLC and identify potential opportunities in those areas.

Companies Mentioned in this Report: High Point Pharmaceuticals, LLC

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- High Point Pharmaceuticals, LLC - Product Pipeline Review - 2012
- Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2013
- CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2013
- Kinex Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Nexgenix Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Arrien Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2013
- High Triglyceridemia - Pipeline Review, H2 2013